By staff writers

June 12, 2019 -- National Health Service (NHS) Scotland plans to advance prostate cancer care by investing 2 million pounds (2.2 million euros) in PET imaging with the radiopharmaceutical gallium-68 (Ga-68) and prostate-specific membrane antigen (PSMA).

With the addition of gallium generators at four centers, Ga-68 PSMA PET scans will be performed at NHS Greater Glasgow and Clyde, NHS Tayside, NHS Lothian, and NHS Grampian. The service is expected to be available in the second quarter of 2020.

"This equipment will allow clinicians to get quick and accurate information about whether advanced prostate cancer has spread to another part of the body," said Jeane Freeman, Scotland's health secretary, in a statement. "If there is no spread, the patient can be reassured, and if there are additional tumors, the medical team can put the right treatment in place."

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking